Glatiramer Acetate Stimulates Regulatory B Cell Functions

Journal of Immunology - United States
doi 10.4049/jimmunol.1801235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Neuroprotection With Glatiramer Acetate: Evidence From the PreCISe Trial

Journal of Neurology
Neurology
2013English

Tumor Promoter Phorbol Myristic Acetate Stimulates Immunoglobulin Secretion Correlated With Growth Cessation in Human B Lymphocyte Cell Lines.

Journal of Clinical Investigation
Medicine
1981English

Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Recurrent Nicolau Syndrome Associated With Subcutaneous Glatiramer Acetate Injection—a Case Report

BMC Neurology
MedicineNeurology
2015English

Hypoxia‐induced Secretion Stimulates Breast Cancer Stem Cell Regulatory Signalling Pathways

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

T Cell Immunity to Glatiramer Acetate Ameliorates Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion by Modulating the Microenvironment

Scientific Reports
Multidisciplinary
2015English

Beta Interferons and Glatiramer Acetate for Treatment of MS: TA Guidance 2018

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Promoting Oligodendrogenesis and Myelin Repair Using the Multiple Sclerosis Medication Glatiramer Acetate

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

CD8+ T Cells Are Required for Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy